(1)
Strober, B.; Sofen, H.; Imafuku, S.; Paul, C.; Gooderham, M.; Spelman, L.; Seo, S. J.; Passeron, T.; Kisa, R. M.; Berger, V.; Vritzali, E.; Hoyt, K.; Colombo, M. J.; Banerjee, S.; Augustin, M.; Stein Gold, L.; Alexis, A.; Thaçi, D.; Blauvelt, A.; Lebwohl, M. Deucravacitinib in Plaque Psoriasis: Maintenance of Response Over 3 Years in the Phase 3 POETYK PSO-1 and PSO-2 Trials. J of Skin 2023, 7, s241.